Introduction

Pharmaceuticals (pharma) companies represent a significant portion of the global economy, given their large scale of operations. Despite their large scale and broad global reach, pharma companies have historically lagged behind other verticals, such as, financial services and telecommunications, in terms of outsourcing initiatives. However, multiple factors (e.g., increasing cost pressure, changing pharma ecosystem, emerging markets, market forces) are now driving pharma buyers to increasingly outsource/offshore processes.

Scope

The analysis is focused on:

• Background on the global pharma industry
• Outsourcing market trends – in-depth analysis of outsourcing transactions in the global pharma vertical
• Trends across buyer adoption of outsourcing and sourcing models (i.e., third-party, captive landscape, JVs)
• Service provider landscape, capabilities and offerings for the pharma industry
• Key future trends to monitor

We have considered pharmaceutical companies such as GlaxoSmithKline, Pfizer, J&J, Novartis, and Merck to be representative of the buyers in this industry.

Contents

This research report provides an in-depth analysis of outsourcing and offshoring in the pharma industry, with focus on outsourcing transactions in the industry, buyer adoption of outsourcing and service provider landscape.

This research report will assist buyers (pharma companies) to understand the activities of other companies in terms of global sourcing of services, including services outsourced/offshored, models used and locations leveraged. It will also inform buyers on service provider offerings for the industry map capabilities of different types of service providers. In case of service provider organizations, this research will provide an overview of key buyers and their operating models, key transactions/contracts in the vertical, capabilities of other service providers in the market and key imperatives for service providers.

The report also comments on the key future trends to watch, for buyers and service providers and other industry stakeholders.